SMARTSET GMV ENDURANGE 40G (ANTIBIOTIC BONE CEMENT)
Report
- Report Number
- 1818910-2017-11952
- Event Type
- Death
- Date Received
- February 6, 2017
- Date of Event
- February 5, 2017
- Report Date
- February 5, 2017
- Manufacturer
- DEPUY CMW ¿ REG. # 9610921
- Product Code
- MBB
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
DHR AND COMPLAINT HISTORY REVIEW COMPLETED. NO NON-CONFORMANCES ON THIS BATCH. FINAL MICRO AND STERILITY TESTS PASSED. A COMPLAINT DATABASE SEARCH FINDS NO ADDITIONAL REPORTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATION. BASED ON THE INABILITY TO FIND ANY OTHER RELATED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT CODE, IT IS REASONABLE TO CONCLUDE THAT THERE ARE NO ANOMALIES WITH REGARD TO MANUFACTURING OR INSPECTION CONTAINED IN THE DEVICE HISTORY RECORDS THAT WOULD CONTRIBUTE TO THE REPORTED EVENT. (B)(4) HAS BEEN REVIEWED AND INCLUDES CARDIOVASCULAR EVENT AS A POTENTIAL HARM WITH A SEVERITY OF 10 AND OCCURRENCE OF 2. THE IFU WAS REVIEWED AND CONTAINS THE FOLLOWING WARNING: "THE FOLLOWING SERIOUS AND FREQUENT ADVERSE REACTIONS MAY OCCUR DURING OR FOLLOWING THE USE OF BONE CEMENT BUT ARE NOT NECESSARILY DIRECTLY RELATED TO THE ACRYLIC BONE CEMENT ITSELF. THE SURGEON SHOULD BE AWARE OF THESE REACTIONS AND BE PREPARED TO TREAT SUCH REACTIONS IF THEY ARE ENCOUNTERED. SERIOUS: MYOCARDIAL INFARCTION, CEREBROVASCULAR ACCIDENT, CARDIAC ARREST, SUDDEN DEATH AND (PULMONARY EMBOLISM. MOST FREQUENT: TRANSITORY FALL IN BLOOD PRESSURE, THROMBOPHLEBITIS, HAEMORRHAGE AND HAEMATOMA LOOSENING OR DISPLACEMENT OF THE PROSTHESIS, SUPERFICIAL OR DEEP WOUND INFECTION, TROCHANTERIC BURSITIS, AND SHORT TERM CARDIAC CONDUCTION IRREGULARITIES." RETAINED SAMPLES WERE CONDITIONED AND TESTED AT AN AMBIENT TEMPERATURE OF 23 DEGREES CELSIUS. THE BATCH WAS TESTED FOR BPO, DMPT, DOUGH TIME/ SETTING TIME AND HANDLING CHARACTERISTICS, AND IR TESTING ON POWDER AND LIQUID COMPONENTS. THE RESULTS WERE REVIEWED AND THESE ARE ALL WITHIN SPECIFICATION. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.
ADDITIONAL NARRATIVE: THIS COMPLAINT IS UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THE INVESTIGATION ONCE IT HAS BEEN COMPLETED. (B)(4). THERE IS NO 510K NUMBER, AS THIS PRODUCT IS SOLD UNDER A DIFFERENT PRODUCT CODE IN THE U.S. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.
THE PATIENT ACCEPTED HEMIARTHROPLASTY ON (B)(6) 2017. THE CEMENT WAS INJECTED TO MEDULLARY CAVITY SMOOTHLY. AFTER 5 MINUTES THE BLOOD PRESSURE OF PATIENT DROPPED AND HEART SLOWED DOWN. THE SURGEON TRIED HIS BEST TO SAVE HER LIFE BUT FAILED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 86767 | SMARTSET GMV ENDURANGE 40G (ANTIBIOTIC BONE CEMENT) | CEMENT / CEMENT ACCESSORY | MBB | DEPUY CMW ¿ REG. # 9610921 | 7822322 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Death |